Clinical Trial Update: Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial update for Zimura in geographic atrophy due to dry age-related macular degeneration. The study is completed and results were posted on M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Zimura (ARC1905)

Snippet

Sponsor: IVERIC bio, Inc. | Conditions: Geographic Atrophy, Dry Age-Related Macular Degeneration | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-05-11